ArticleCureus2025

Understanding the Factors Related to Early Discontinuation of Lutetium-177 Vipivotide Treatment in Men With Metastatic Castration-Resistant Prostate Cancer at a Single Institution.

Mannat Bedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.